Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-05-17
2010-12-28
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S431000, C514S450000, C540S593000, C540S604000, C540S611000, C549S009000, C549S355000
Reexamination Certificate
active
07858613
ABSTRACT:
The invention relates to substituted benzo-condensed cycloheptanone derivatives, to methods for producing them, to drugs containing said compounds and to the use of said compounds for producing drugs.
REFERENCES:
patent: 6384072 (2002-05-01), Hattori et al.
patent: 1 913 199 (1970-09-01), None
patent: 0 383 318 (1990-08-01), None
patent: 0 567 138 (1993-10-01), None
patent: 1 218 778 (1971-01-01), None
patent: 1 249 261 (1971-10-01), None
patent: 61-129179 (1986-06-01), None
patent: WO 98/36749 (1998-08-01), None
patent: WO99/24397 (1999-05-01), None
patent: WO 2004/052845 (2004-06-01), None
patent: WO 2005/044802 (2005-05-01), None
Vippagunta et. al., Advanced Drug Delivery Reviews, 2001, Elsevier Science, 48, pp. 3-26.
Corresponding German Search Report dated Jan. 17, 2006 with English translation of relevant portion (Nine (9) pages).
Written Opinion of the International Searching Authority (Form PCT/ISA/237) along with Form PCT/IB/338 and Form PCT/IB/373 with English translation of relevant portion (Fourteen (14) pages).
Corresponding International Search Report dated Oct. 6, 2006 (Form PCT/ISA/210) with English translation of relevant portion (Seven (7) pages).
John J. Sciarra, PhD et al., “Aerosols”, Remington's Pharmaceutical Sciences, 1985, pp. 1662-1677, Chapter 93, 17thEdition, Mack Publishing Company, Easton, Pa.
Mark A. Longer et al., “Sustained-Release Drug Delivery Systems”, Remington's Pharmaceutical Sciences, 1985, pp. 1644-1661, Chapter 92, 17thEdition, Mack Publishing Company, Easton, Pa.
Stuart C. Porter, Ph.D., “Coating of Pharmaceutical Dosage Forms”, Remington's Pharmaceutical Sciences, 1985, pp. 1633-1643, Chapter 91, 17thEdition, Mack Publishing Company, Easton, Pa.
Robert E. King, Ph.D. et al., “Oral Solid Dosage Forms”, Remington's Pharmaceutical Sciences, 1985, pp. 1603-1632, Chapter 90, 17thEdition, Mack Publishing Company, Easton, Pa.
Edward G. Rippie, Ph.D. et al., “Powders”, Remington's Pharmaceutical Sciences, 1985, pp. 1585-1602, Chapter 89, 17thEdition, Mack Publishing Company, Easton, Pa.
Lawrence H. Block, Ph.D., “Medicated Applications”, Remington's Pharmaceutical Sciences, 1985, pp. 1567-1584, Chapter 88, 17thEdition, Mack Publishing Company, Easton, Pa.
John D. Mullins, Ph.D., “Ophthalmic Preparations”, Remington's Pharmaceutical Sciences, 1985, pp. 1553-1566, Chapter 87, 17thEdition, Mack Publishing Company, Easton, Pa.
Salvatore J. Turco, Pharm.D. et al., “Intravenous Admixtures”, Remington's Pharmaceutical Sciences, 1985, pp. 1542-1552, Chapter 86, 17thEdition, Mack Publishing Company, Easton, Pa.
Kenneth E. Avis, DSC, “Parenteral Preparations”, Remington's Pharmaceutical Sciences, 1985, pp. 1518-1541, Chapter 85, 17thEdition, Mack Publishing Company, Easton, Pa.
J. G. Nairn, Ph.D., “Solutions, Emulsions, Suspensions and Extractives”, Remington's Pharmaceutical Sciences, 1985, pp. 1492-1517, Chapter 84, 17thEdition, Mack Publishing Company, Easton, Pa.
Clyde R. Erskine, Jr, “Quality Assurance and Control”, Remington's Pharmaceutical Sciences, 1985, pp. 1487-1491, Chapter 83, 17thEdition, Mack Publishing Company, Easton, Pa.
Carl J. Lintner Ph.D., “Stability of Pharmaceutical Products”, Remington's Pharmaceutical Sciences, 1985, pp. 1478-1486, Chapter 82, 17thEdition, Mack Publishing Company, Easton, Pa.
Robert L. Giles, BA, et al., “Plastic Packaging Materials”, Remington's Pharmaceutical Sciences, 1985, pp. 1473-1477, Chapter 81, 17thEdition, Mack Publishing Company, Easton, Pa.
Frederick P. Siegel Ph.D., “Tonicity, Osmoticity, Osmolality, and Osmolarity” Remington's Pharmaceutical Sciences, 1985, pp. 1455-1472, Chapter 80, 17thEdition, Mack Publishing Company, Easton, Pa.
G. Briggs Phillips, Ph.D. “Sterilization”, Remington's Pharmaceutical Sciences, 1985, pp. 1443-1454, Chapter 79, 17thEdition, Mack Publishing Company, Easton, Pa.
Adelbert M. Knevel, Ph.D., “Separation”, Remington's Pharmaceutical Sciences, 1985, pp. 1432-1442, Chapter 78, 17thEdition, Mack Publishing Company, Easton, Pa.
Anthony R. Disanto, Ph.D., “Bioavailability and Bioequivalency Testing”, Remington's Pharmaceutical Sciences, 1985, pp. 1424-1431, Chapter 77, 17thEdition, Mack Publishing Company, Easton, Pa.
Louis J. Ravin, Ph.D., “Preformulation”, Remington's Pharmaceutical Sciences, 1985, pp. 1409-1423, Chapter 76, 17thEdition, Mack Publishing Company, Easton, Pa.
Terence J. Coderre et al., “Contribution of Central Neuroplasticity to Pathological Pain: Review of Clinical and Experimental Evidence”, Pain, 1993, pp. 259-285, vol. 52, Elsevier Science Publishers B.V.
L. C. Hendershot et al., Antagonism of the Frequency of Phenylquinone-Induced Writhing in the Mouse by Weak Analgesics and Nonanalgesics:, J. Pharmacol. Exp. Ther., Sep. 19, 1958, pp. 237-240, vol. 125.
Bernd Eistert et al., “Weitere Umsetzungen von Phenanthrenchinon mit Aliphatischen Diazoverbindungen”. Chem. Ber., 1968, pp. 84-33, vol. 101.
B.D. Astill et al., “The Synthesis of 1-Benzazepine Derivatives as Model Compounds Related to Apo-β-Erythroidine1,2”, Journal of the American Chemical Society, Aug. 5, 1955, pp. 4079-4084, vol. 77, XP-002397577.
Christopher S.J. Walpole et al., “The Discovery of Capsazepine, the First Competitive Antagonist of the Sensory Neuron Excitants Capsaicin and Resiniferatoxin”, Journal of Medicinal Chemistry, 1994, pp. 1942-1954, vol. 37, American Chemical Society, XP-002397578.
Frank Robert
Haurand Michael
Hennies Hagen-Heinrich
Hinze Claudia
Jostock Ruth
Crowell & Moring LLP
Gruenenthal GmbH
Padmanabhan Sreeni
Pihonak Sarah
LandOfFree
Substituted benzo-condensed cycloheptanone derivatives and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzo-condensed cycloheptanone derivatives and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzo-condensed cycloheptanone derivatives and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4171884